Clinical Trials Logo

Clinical Trial Summary

To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired frontopolar cortex (FPC) -cerebellar pulses on episodic methamphetamine use in patients on methadone maintenance treatment and to develop a novel physiotherapeutic intervention to optimise the treatment and management of addicted patients.


Clinical Trial Description

Numerous studies have shown that impaired FPC-cerebellar functional connectivity leads to impaired social preferences and behavioural flexibility and more persistent drug use in addicts. Cerebellar and FPC paired-pulse rTMS interventions may enhance functional connectivity, effectively modulate cerebellar-prefrontal loops, reduce craving, improve cognitive flexibility, and reduce relapse risk. The aim of this project is to explore the mechanism and efficacy of a novel FPC-cerebellar paired-pulse rTMS intervention model on occasional methamphetamine use in methadone maintenance patients, to develop novel physiotherapy interventions, and to optimise the treatment and management of addicted patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06457230
Study type Interventional
Source Shanghai Mental Health Center
Contact Min Zhao, PhD
Phone 64387250
Email drminzhao@gmail.com
Status Recruiting
Phase N/A
Start date September 2024
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06165198 - Individualized Neuromodulation for the Core Clinical Features of Drug Addiction N/A
Completed NCT03736317 - Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorder N/A
Completed NCT03382379 - Transcranial Direct Current Stimulation to Modulate Top-Down Regulation for Drug Craving in Methamphetamine Use Disorder Phase 1/Phase 2
Completed NCT03922646 - Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder N/A
Not yet recruiting NCT06454474 - Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction N/A
Completed NCT02881177 - Oxytocin HIV Meth Study Phase 1
Recruiting NCT06457243 - Closed-loop cTBS for the Core Clinical Features of Methamphetamine Use Disorder N/A